Penetrium Bioscience voting rights stake unchanged at 37.57% after pledge contract revision filing
Hyundai Bioscience filed an amended large-shareholding report in Penetrium, keeping its voting stake at 24,030,335 shares, or 37.57%. The update reflected a change in share-pledge arrangements, cutting shares under key contracts to 12,850,000 from 13,070,000. The disclosure was dated Oct. 14, 2026, with the obligation